Abstract
Purpose
We aimed to evaluate the power of 18F-fluorocholine (FCH) positron emission tomography/magnetic resonance (PET/MR) imaging in unlocalized primary hyperparathyroidism.
Methods
Thirty-four patients were included. In 17/34 patients, PET/MR was performed immediately after a negative 18F-FCH PET/CT. Sensitivity, specificity, positive and negative predictive values were calculated for MR only (blinded to PET data) and PET only (blinded to MR data) findings.
Results
18F-FCH PET/MR was positive in 26/34 (76%) patients. PET/MR was also positive in 12/17 (71%) patients with a negative PET/CT. Among 11/34 (32%) patients where 18F-FCH PET-only and MR-only results were discordant, MR was false positive in 7/11 patients (3/7 of the lesions were not 18F-FCH avid and in 4/7 of them PET and MRI pointed different locations. Postoperative histopathology revealed that 18F-FCH-positive ones were true positives). Sensitivity, specificity, PPV, NPV and accuracy of neck MR evaluated blinded to PET data were 80%, 50%, 70%, 64% and 68%, respectively, and all were calculated as 100% for PET/MR.
Conclusion
18F-FCH PET/MR is very effective in preoperative localization of parathyroid adenomas even if 18F-FCH PET/CT is negative. Neck MR alone is insufficient in detecting parathyroid adenomas but PET/MR combination helps in precise localisation.
Similar content being viewed by others
References
Ruda JM, Hollenbeak CS, Stack BCA Jr (2005) systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 132:359
Eslamy HK, Ziessman HA (2008) Parathyroid scintigraphy in patients with primary hyperparathyroidism: 99mTc sestamibi SPECT and SPECT/CT. Radiographics 28:1461
Treglia G, Piccardo A, Imperiale A, Strobel K, Kaufmann PA, Prior JO, Giovanella L (2019) Diagnostic performance of choline PET for detection of hyper functioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 46:751–765
Kabala JE (2008) Computed tomography and magnetic resonance imaging in diseases of the thyroid and parathyroid. Eur J Radiol 66:480–492
Sacconi B, Argirò R, Diacinti D, Iannarelli A, Bezzi M, Cipriani C, Pisani D, Cipolla V, De Felice C, Minisola S, Catalano C (2016) MR appearance of parathyroid adenomas at 3 T in patients with primary hyperparathyroidism: what radiologists need to know for pre-operative localization. Eur Radiol 26(3):664–673
Drzezga A, Souvatzoglou M, Eiber M, Beer AJ, Fürst S, Martinez-Möller A, Nekolla SG, Ziegler S, Ganter C, Rummeny EJ, Schwaiger M (2012) First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses. J Nucl Med 53(6):845–855
Balyasnikova S, Löfgren J, de Nijs R, Zamogilnaya Y, Højgaard L, Fischer BM (2012) PET/MR in oncology: an introduction with focus on MR and future perspectives for hybrid imaging. Am J Nucl Med Mol Imaging 2(4):458–474
Broos W, van der Zant FM, Knol R, Wondergem M (2019) Choline PET/CT in parathyroid imaging: a systematic review. Nucl Med Commun 40(2):96–105
Hocevar M, Lezaic L, Rep S, Zaletel K, Kocjan T, Sever MJ, Zgajnar J, Peric B (2017) Focused parathyroidectomy without intraoperative parathormone testing is safe after pre-operative localization with 18F-Fluorocholine PET/CT. Eur J Surg Oncol 43(1):133–137
Broos W, Wondergem M, Knol R, van der Zant FM (2019) Parathyroid imaging with 18F-fluorocholine PET/CT as a first-line imaging modality in primary hyperparathyroidism: a retrospective cohort study. EJNMMI Res 9(1):72
Wakamatsu H, Noguchi S, Yamashita H, Yamashita H, Tamura S, Jinnouchi S, Nagamachi S, Futami S (2003) Parathyroid scintigraphy with 99mTc-MIBI and 123I subtraction: a comparison with magnetic resonance imaging and ultrasonography. Nucl Med Commun 24(7):755–762
Mahajan A, Starker LF, Ghita M, Udelsman R, Brink JA, Carling T (2012) Parathyroid four-dimensional computed tomography: evaluation of radiation dose exposure during preoperative localization of parathyroid tumors in primary hyperparathyroidism. World J Surg 36(6):1335–1339
Aroquaux A, Rager O, Poncet A, Delattre BM, Ratib O, Becker CD, Dulguerov P, Dulguerov N, Zaidi H, Becker M (2014) Detection and quantification of focal uptake in head and neck tumours: (18)F-FDG PET/MR versus PET/CT. Eur J Nucl Med Mol Imaging 41(3):462–475
Numerow LM, Morita ET, Clark OH, Higgins GB (1995) Hyperparathyroidism: a comparison of sestamibi scintigraphy, MRI, and ultrasonography. J Magn Reson Imaging 5(6):702–708
McDermott VG, Fernandez RJ, Meakem TJ 3rd, Stolpen AH, Spritzer CE, Gefter WB (1996) Preoperative MR imaging in hyperparathyroidism: results and factors affecting parathyroid detection. AJR Am J Roentgenol 166(3):705–710
Ernst O (2009) Hyperparathyroïdie: applications du scanner et de l’IRM [Hyperparathyroidism: CT and MR findings]. J Radiol 90(3 Pt 2):409–412
Gotway MB, Higgins CB (2000) MR imaging of the thyroid and parathyroid glands. Magn Reson Imaging Clin N Am 8(1):163–168
Lopez Hänninen E, Vogl TJ, Steinmüller T, Ricke J, Neuhaus P, Felix R (2000) Preoperative contrast-enhanced MRI of the parathyroid glands in hyperparathyroidism. Invest Radiol 35(7):426–430
Gotway MB, Reddy GP, Webb WR, Morita ET, Clark OH, Higgins CB (2001) Comparison between MR imaging and 99mTc MIBI scintigraphy in the evaluation of recurrent of persistent hyperparathyroidism. Radiology 218(3):783–790
Slomka PJ, Pan T, Germano G (2016) Recent advances and future progress in PET instrumentation. Semin Nucl Med 46(1):5–19
Broos WAM, Wondergem M, van der Zant FM, Knol RJJ (2019) Dual-time-point 18F-Fluorocholine PET/CT in parathyroid imaging. J Nucl Med 60(11):1605–1610
Rep S, Hocevar M, Vaupotic J, Zdesar U, Zaletel K, Lezaic L (2018) 18F-choline PET/CT for parathyroid scintigraphy: significantly lower radiation exposure of patients in comparison to conventional nuclear medicine imaging approaches. J Radiol Prot 38(1):343–356
Funding
None to declare.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Araz, M., Nak, D., Soydal, Ç. et al. Detectability of 18F-choline PET/MR in primary hyperparathyroidism. Eur Arch Otorhinolaryngol 279, 2583–2589 (2022). https://doi.org/10.1007/s00405-021-07046-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-021-07046-3